Topic: Clinical trial
Clinical Trial Opportunities in India Report
A joint report titled “Clinical Trial Opportunities in India” Report was released recently by the PwC India and US-India Chamber of Commerce (USAIC). Key findings of the Report:...
Lecanemab Approved for Alzheimer’s Treatment
The US Food and Drug Administration (FDA) has approved lecanemab, a monoclonal antibody developed by Eisai and Biogen, for the treatment of Alzheimer’s disease. Lecanemab is the second...
Bharat Biotech Nasal Booster Trials
The Drug controller General of India has approved the COVAXIN booster trials. These boosters were produced by Bharat Biotech, the same company that produces COVAXIN. The boosters are...
COVAXIN to use Alhydroxiquim-II to boost Immune Response
The first COVID-19 vaccine, COVAXIN is currently in phase II trials in the country. The vaccine is to use Alhydroxiquim-II to boost the immune system. Highlights COVAXIN has...
ICMR to launch COVAXIN on August 15
On July 2, 2020, Indian Council of Medical Research announced that it is to launch COVAXIN, India’s first COVID-19 vaccine by August 15. Highlights There are 12 institutes...
